Macrolide antibiotics directly reduce active oxygen generation by neutrophils in human peripheral blood

Kurume Medical Journal

Volumn 50, Issue 1-2, 2003, Pages 9-15

  Sugihara, Eiichiro ^a,b,c   Koyanagi, Takeshi ^b   Niizeki, Takashi ^b   Hirota, Naotoshi ^b   Nagafuchi, Masako ^a,b   Yamada, Kazuhiko ^a   Kido, Yasuko ^a   Ono, Noriyuki ^b   Rikimaru, Toru ^a   Aizawa, Hisamichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Chikugo City Hospital   (Japan)

^c Chikugo City Hospital   (Japan)

Author keywords

Diffuse panbronchiolitis; Macrolide antibiotics; Neutrophil function; Neutrophils; Superoxide

Indexed keywords

AZITHROMYCIN; ERYTHROMYCIN; MACROLIDE; REACTIVE OXYGEN METABOLITE; ROKITAMYCIN;

ARTICLE; BLOOD; BRONCHIOLITIS; CHRONIC RESPIRATORY TRACT DISEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOMODULATION; MONONUCLEAR CELL; NEUTROPHIL; NORMAL HUMAN; PANBRONCHIOLITIS;

EID: 0042974273     PISSN: 00235679     EISSN: None     Source Type: Journal    
DOI: 10.2739/kurumemedj.50.9     Document Type: Article

References (13)

1. Yamanaka A, Saeki S, and Saito K. The problems in chronic obstructive plumonary disease: Especially concerning about diffuse panbronchiolitis. Intern Med 1969; 23:442-445.
2. Homma H, Yamanaka A, Tanimoto S, Tamura M, Chijimatsu Y et al. Diffuse panbronchiolitis: A disease of the transitional zone of the lung. Chest 1983; 95:1342-1344.
3. Ichikawa Y, Koga H, Tanaka M, Nakamura M, Tokunaga N et al. Neutrophilia in bronchoalveolar lavage fluid of diffuse panbronchiolitis. Chest 1990; 98:917-923.
4. Bringham K. L. Role of free radicals in lung injury. Chest 1986; 89:859-863.
5. Ichikawa Y, Ninomiya H, Yano T, and Oizumi K. Erythromycin reduce neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am Rev Respir Dis 1992; 146:196-203.
6. Kudoh S, Uetake T, Hagiwara K, Hirayama M, Lung-Hong Hus et al. Clinical effect of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. J Jpn Thorac Dis 1987; 25:632-642.
7. Kadota J, Sakito O, Kohno S, Sawa H, Oda H et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993; 147:153-159.
8. Oda H, Kadota J, and Hara K. Erythromycin inhibits neutrophil chemotacis in blonchioli of diffuse panbronchiolitis. Chest 1994; 106:1116-1123.
9. Honjo M, Fugita I, Hamasaki Y, Miyazaki M, and Miyazaki S. Erythromycin dose not directly affect neutrophil functions. Chest 1994; 105:520-523.
10. Hirata T, Matsunabe S, Matsui Y, Kado M, Kino M et al. Effect of erythromycin on the generation of neutrophil chemiluminescence in vitro. J. Jpn Thorac Dis 1990; 28:1066-1071.
11. Anderson R. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generayion and autooxidation. J. Infect Dises 1989; 159:966-973.
12. D Torr, M Broggini, V Botta, C Sampietro, R Busarello et al. In vitro and ex vivo effects of recent and new macrolide antibiotics on chemotaxis of human polymorphonuculer leukocytes. J of chemotherapy 1991; 3:236-239.
13. Shindo N. Effects of macrolide antimicrobials on the cytosolic calcium levels and functions of human polymorphonuclear leukocytes. Jpn J Chemother 1997; 45:15-20.